Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 942
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03(15)(5))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 210
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-04(12)(a))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)												12 Months Ended
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	May 23, 2025	May 22, 2025	Apr. 04, 2025	Mar. 21, 2025	Feb. 06, 2025	Dec. 10, 2024	Oct. 01, 2024	Sep. 17, 2024	Sep. 16, 2024	Jan. 04, 2024	Dec. 09, 2019	Dec. 31, 2025	Dec. 31, 2024	Dec. 31, 2023	Jun. 23, 2025	Feb. 26, 2025	Jun. 20, 2013
Stockholders' Equity, Reverse Stock Split										1 for 20
Common Stock, Shares, Outstanding												9,092,518	8,092,518
Stock Issued During Period, Value, Issued for Services												$ 190,000
Number of options forfeited													5,333
Stock based compensation expense												$ 0	$ 0
Common Stock, Par or Stated Value Per Share												$ 0.02	$ 0.02
Shares issued for payment of legal fees															100,000	36,433
Legal fees received															$ 161,000	$ 29,000
Option granted							880,000					3,200,000
Purchase price per share							$ 3.00
Proceeds from grants							$ 2,640,000
Fair value grants							$ 50,000
Sales General and Administrative Expenses [Member]
Stock based compensation expense												$ 19,000
Equity Incentive Plan [Member]
Stock Issued During Period, Shares, Issued for Services					1,000,000
Stock Issued During Period, Value, Issued for Services					$ 870,000
Impact Bio Medical Inc [Member]
Number of common stock sold	45,400	115,600	890,800	499,800
Number of shares sold	45,400	115,600	890,800	499,800
Value of shares sold	$ 24,000	$ 63,000	$ 845,000	$ 1,500,000
Impact BioMedical, Inc. [Member] \| IPO [Member]
Number of common stock sold									1,500,000
Common Stock, Par or Stated Value Per Share									$ 0.001
Share Price									$ 3.00
Proceeds from Issuance Initial Public Offering								$ 3,726,000
Sale of Stock, Description of Transaction												A final prospectus relating to this Offering was filed with the Commission on September 16, 2024. The shares of Common Stock were approved to list on the NYSE American under the symbol “IBO” and began trading there on September 16, 2024. The Company also issued warrants to the Representative and its affiliates (the “Representative’s Warrants”) warrants to purchase the number of shares of Common Stock in the aggregate equal to 5% of the Common Stock to be issued and sold in this offering (including any Shares of Common Stock sold upon exercise of the over-allotment option, if applicable). The Representative’s Warrants are exercisable for a price per share equal to 125% of the public offering price. The warrants are exercisable at any time, in whole or in part, commencing nine (9) months from the date of commencement of sales of the offering and ending on the third anniversary thereof. These warrants were not exercised and expired in September 2025.
Common Stock [Member]
Number of common stock sold													1,025,746
Stock Issued During Period, Shares, Issued for Services
Stock Issued During Period, Value, Issued for Services
Securities Purchase Agreement [Member] \| Common Stock [Member]
Number of common stock sold						820,597
Value of common stock sold						$ 803,000
Securities Purchase Agreement [Member] \| Common Stock [Member] \| Heng Fai Ambrose Chan [Member]
Number of common stock sold						205,149
Value of common stock sold						$ 197,000
Securities Purchase Agreement [Member] \| Common Stock [Member] \| Alset, Inc. [Member]
Number of common stock sold						820,597
Value of common stock sold						$ 803,000
2013 Plan [Member] \| Share-Based Payment Arrangement, Option [Member]
Number of shares authorized for issuance																	50,000
Number of shares available													0
2020 Plan [Member] \| Share-Based Payment Arrangement, Option [Member]
Number of shares authorized for issuance											241,204
Number of shares available												673,436
Options description											In addition, on the first day of each calendar year, for a period of not more than ten (10) years, commencing January 1, 2021, or the first business day of the calendar year if the first day of the calendar year falls on a Saturday or Sunday, the shares available under this plan will automatically increase in an amount equal to the lesser of (i) five percent (5%) of the total number of shares of Common Stock outstanding as of December 31 of the preceding fiscal year or (ii) such number of shares of Common Stock as determined by the Board of Directors.
Two Thousand And Twenty Three Plan [Member] \| Share-Based Payment Arrangement, Option [Member]
Number of shares authorized for issuance														18,762,000
Number of shares available												18,037,079
Options description														In addition, on the first day of each calendar year, for a period of not more than ten (10) years, commencing January 1, 2025, or the first business day of the calendar year if the first day of the calendar year falls on a Saturday or Sunday, the shares available under this plan will automatically increase in an amount equal to the lesser of (i) two percent (2%) of the total number of shares of Common Stock outstanding as of December 31 of the preceding fiscal year or (ii) such number of shares of Common Stock as determined by the Board of Directors.
Pre Reverse Stock Split [Member]
Common Stock, Shares, Outstanding													140,264,240	139,017,000
Post Reverse Stock Split [Member]
Common Stock, Shares, Outstanding													7,066,772	6,950,858